The role of hypoxia-inducible factors in tumorigenesis

Rankin, E B, Giaccia, A J·2008·Cell Death & Differentiation

Cited by (808)

Items 201–300 of 808

  1. HSulf-1 Modulates FGF2- and Hypoxia-Mediated Migration and Invasion of Breast Cancer Cells
    Ashwani Khurana, Peng Liu, Pasquale Mellone, Laura Lorenzon, Bruno Vincenzi, Kaustubh Datta, Bo Yang, Robert J. Linhardt, Wilma L. Lingle, JEREMY R. CHIEN et al. · 2011 · Cancer Research
  2. Overexpression of von Hippel–Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice
    Jizhou Wang, Yong Ma, Hongchi Jiang, Huaqiang Zhu, Lianxin Liu, Bei Sun, Shangha Pan, Geoffrey Wayne Krissansen, Xueying Sun · 2010 · Journal of Hepatology
  3. Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis
    Zichang Yang, Xiaonan Shi, Ce Li, Xiaoxun Wang, Kezuo Hou, Zhi Li, Xiaojie Zhang, Yibo Fan, Xiujuan Qu, Xiaofang Che et al. · 2018 · Experimental Cell Research
  4. Development of targeted angiogenic medicine
    Sonja Loges, Carmen Roncal, Peter Carmeliet · 2008 · Journal of Thrombosis and Haemostasis
  5. Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells
    Rafael Moreno‐Sánchez, Álvaro Marín‐Hernández, Juan Carlos Gallardo‐Pérez, Héctor Quezada, Rusely Encalada, Sara Rodríguez‐Enríquez, Emma Saavedra · 2011 · Journal of Cellular Biochemistry
  6. Hypoxia-Inducible Factor-1alpha and MAPK Co-Regulate Activation of Hepatic Stellate Cells upon Hypoxia Stimulation
    Yueqin Wang, Yimin Huang, Fei Guan, Yan Xiao, Jing Deng, Huoying Chen, Xiaolin Chen, Jianrong Li, Hanju Huang, Chunwei Shi · 2013 · PLoS ONE
  7. Caspase-mediated Cleavage of RNA-binding Protein HuR Regulates c-Myc Protein Expression after Hypoxic Stress
    Sudha Talwar, Junfei Jin, Brittany L. Carroll, Angen Liu, Marion Boyd Gillespie, Viswanathan Palanisamy · 2011 · Journal of Biological Chemistry
  8. The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells
    Susanna Teppo, Elias Sundquist, Marilena Vered, Heidi Holappa, Juha Parkkisenniemi, Tatiana Rinaldi, Petri P Lehenkari, Reidar A. Grenman, Dan Dayan, Juha Risteli et al. · 2012 · Experimental Cell Research
  9. PET/CT imaging of renal cell carcinoma with 18F-VM4-037: a phase II pilot study
    Barış Türkbey, Maria Liza Lindenberg, Stephen Adler, Karen Kurdziel, Yolanda L. McKinney, Juanita Weaver, Cathy D. Vocke, Miriam R. Anver, Gennady Bratslavsky, Philip C. Eclarinal et al. · 2015 · Abdominal Radiology
  10. The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
    Jiuda Zhao, Feng Du, Yang Luo, Guoshuang Shen, Fangchao Zheng, Binghe Xu · 2015 · Cancer Treatment Reviews
  11. Beclin-1 and hypoxia-inducible factor-1α genes expression: Potential biomarkers in acute leukemia patients
    Sara M. Radwan, Nadia Μ. Hamdy, Hany Mohamed Abd-Allah Hegab, Hala Osman EL-Mesallamy · 2016 · Cancer Biomarkers
  12. Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review)
    Xingwen Han, Wenji Wang, Jingjing He, Lei Jiang, Xun� Li · 2019 · Oncology Letters
  13. Serum HIF-1α and VEGF Levels Pre- and Post-TACE in Patients with Primary Liver Cancer
    Zhongzhi Jia, Guo-min Jiang, Yao-liang Feng · 2011 · Chinese Medical Sciences Journal
  14. S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
    Yiren Xiao, Hongjuan Zhao, Lei Tian, Rosalie Nolley, Anh N. Diep, Anne Ernst, Katherine Cynthia Fuh, Yu Rebecca Miao, Rie von Eyben, John T. Leppert et al. · 2019 · Cancer Research
  15. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells
    Stefania Cannito, Cristian Turato, Claudia Paternostro, Alessandra Biasiolo, Sebastiano Colombatto, Irene Cambieri, Santina Quarta, Erica Novo, Elisabetta Morello, Gianmarco Villano et al. · 2014 · Oncotarget
  16. Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
    Enrica Borsi, Carolina Terragna, Annamaria Brioli, Paola Tacchetti, Marina Martello, Michèle Cavo · 2014 · Translational research
  17. Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment
    Helmut A Greim, A. Hartwig, Ulrike Reuter, Hans-Bernhard Richter-Reichhelm, Heinz Walter Thielmann · 2009 · Critical Reviews in Toxicology
  18. TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity
    Marina Stantic, Habib A. M. Sakil, Hanna Zirath, Trixy Fang, Gema Sanz, Alejandro Fernandez-Woodbridge, Ana Marin, Evelyn Susanto, Tak W. Mak, Marie Arsenian‐Henriksson et al. · 2014 · Proceedings of the National Academy of Sciences
  19. Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1α pre-mRNA in mice and in vitro
    Yoon-Mi Lee, Ji-Hong Lim, Haejin Yoon, Yang‐Sook Chun, Jong‐Wan Park · 2010 · Hepatology
  20. Inhibition of hypoxia inducible factor by phenethyl isothiocyanate
    Xiuhong Wang, Breeze E. Cavell, Sharifah Sakinah Syed Alwi, Graham Packham · 2009 · Biochemical Pharmacology
  21. Mitochondrial biology in cancer stem cells
    Rute Loureiro, Katia A. Mesquita, Silvia Magalhaes Novais, Paulo Jorge Oliveira, Ignacio Vega‐Naredo · 2017 · Seminars in Cancer Biology
  22. A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin
    Tolonen, Jussi-Pekka, Heikkilä, Minna, Malinen, Marjo, Lee, Hang-Mao, Palvimo, Jorma J., Wei, Gong-Hong, Myllyharju, Johanna · 2020 · Cellular and Molecular Life Sciences
  23. S-Nitrosylation in Tumor Microenvironment
    Vandana Sharma, Veani Fernando, Joshua Letson, Yashna Walia, Xunzhen Zheng, Daniel Fackelman, Saori Furuta · 2021 · International Journal of Molecular Sciences
  24. Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
    Rituparna Ghosh, Priya Samanta, Rupali Sarkar, Souradeep Biswas, Prosenjit Saha, Subhadip Hajra, Arijit Bhowmik · 2022 · Molecules
  25. Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer
    Saba Musleh Ud Din, S. Streit, Bao Tran Huynh, Caroline K. Hana, Anna Ninny J. Abraham, Atif Mahmoud Hussein · 2024 · International Journal of Molecular Sciences
  26. Glioma Revisited: From Neurogenesis and Cancer Stem Cells to the Epigenetic Regulation of the Niche
    Felipe de Almeida Sassi, Algemir Lunardi Brunetto, Gilberto Schwartsmann, Rafael Roesler, Ana Lúcia Abujamra · 2012 · Journal of Oncology
  27. Drosophila Genome-Wide RNAi Screen Identifies Multiple Regulators of HIF–Dependent Transcription in Hypoxia
    Andrés Dekanty, Nuria Magdalena Romero, Agustina P. Bertolin, María Gabriela Thomas, Claudia C. Leishman, Joel I. Perez-Perri, Graciela Lidia Boccaccio, Pablo Wappner · 2010 · PLoS Genetics
  28. Co‐expression of Hif1α and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients
    Alexander W. Eckert, M.H.W. Lautner, Andreas Schütze, Kristel Bolte, Matthias Bache, Matthias Kappler, Johannes Schubert, Helge W. Taubert, Udo Bilkenroth · 2009 · Journal of Oral Pathology and Medicine
  29. Role of aquaporins in cell proliferation: What else beyond water permeability?
    Ana Galán‐Cobo, Reposo Ramírez‐Lorca, Miriam Echevarrı́a · 2016 · Channels
  30. EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
    Bo Pang, Xiangrong Zheng, Jingxia Tian, Taihong Gao, Guangyan Gu, Rui Zhang, Yibing Fu, Qi Pang, Xingang Li, Qian Liu · 2016 · Oncotarget
  31. RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect
    Chen‐Song Zhang, Qi Liu, Mengqi Li, Sheng‐Cai Lin, Yongying Peng, Di Wu, Terytty Yang Li, Qiang Fu, Weiping Jia, Xinjun Wang et al. · 2015 · Cell Research
  32. Role of exosomes and microvesicles in hypoxia‐associated tumour development and cardiovascular disease
    Mattias Belting, Helena C. Christianson · 2015 · Journal of Internal Medicine
  33. Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia
    Shaliny Ramachandran, Jonathan Ient, Eva‐Leonne Göttgens, Adam J. Krieg, Ester M. Hammond · 2015 · Genes
  34. Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylation
    Anna Serra‐Pérez, Anna Maria Planas, Analía Núñez-O’Mara, Edurne Berra, Judit García‐Villoria, Antònia Ribes, Tomàs Santalucı́a · 2010 · Journal of Biological Chemistry
  35. Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth
    Daniel W. Fults, Michael D. Taylor, Livia Garzia · 2019 · Journal of Neurosurgery Pediatrics
  36. Severe OSA associated with higher risk of mortality in stage III and IV lung cancer
    Huang, Hung-Yu, Lin, Shih-Wei, Chuang, Li-Pang, Wang, Chih-Liang, Sun, Ming-Hui, Li, Hsueh-Yu, Chang, Chee-Jen, Chang, Shu-Chen, Yang, Cheng-Ta, Chen, Ning-Hung · 2020 · Journal of Clinical Sleep Medicine
  37. Chaetocin: A review of its anticancer potentials and mechanisms
    Hangyu Jiang, Yuqi Li, Xiaocong Xiang, Zhili Tang, Kang Liu, Qiang Su, Xiaofen Zhang, Lin Li · 2021 · European Journal of Pharmacology
  38. Targeting hypoxia in solid and haematological malignancies
    Bill Harris, Sana Saleem, Natalie Cook, Emma J Searle · 2022 · Journal of Experimental & Clinical Cancer Research
  39. Increased levels of hypoxia‐inducible factor‐1α are associated with Bcl‐xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma
    Changbao Chen, Hua Zhou, Feng Wei, Liang Jiang, Xiaoguang Liu, Zhongjun Liu, Qingjun Ma · 2010 · Journal of Orthopaedic Research®
  40. Pancreatic Cancer and Its Microenvironment—Recent Advances and Current Controversies
    Kinga B. Stopa, Agnieszka A. Kusiak, Mateusz D. Szopa, Paweł E. Ferdek, Monika A. Jakubowska · 2020 · International Journal of Molecular Sciences
  41. PPARγ and RXR Ligands Disrupt the Inflammatory Cross‐talk in the Hypoxic Breast Cancer Stem Cells Niche
    Alessio Papi, Sabrina De Carolis, Sara Bertoni, Gianluca Storci, Virginia Sceberras, Donatella Santini, Claudio Ceccarelli, Mario Taffurelli, Marina Orlandi, Massimiliano Bonafè · 2014 · Journal of Cellular Physiology
  42. Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases
    Meghna Talekar, Thanh-Huyen Tran, Mansoor M. Amiji · 2015 · The AAPS Journal
  43. Molecular, functional, and gene expression analysis of zebrafish hypoxia-inducible factor-3α
    Peng Zhang, Ling Lu, Qing Yao, Yun Li, Jianfeng Zhou, Yunzhang Liu, Cunming Duan · 2012 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  44. PKCδ activation mediates angiogenesis via NADPH oxidase activity in PC‐3 prostate cancer cells
    Jeewon Kim, Tomoyoshi Koyanagi, Daria Mochly‐Rosen · 2010 · The Prostate
  45. Action Sites and Clinical Application of HIF-1α Inhibitors
    Renfeng Xu, Fan Wang, Hongqin Yang, Zhengchao Wang · 2022 · Molecules
  46. Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?
    Caleb Kim, Lara Emily Davis, Catherine Michelle Albert, Brian L. Samuels, Jesse L. Roberts, Michael J. Wagner · 2023 · Cancers
  47. Dysregulated D-dopachrome Tautomerase, a Hypoxia-inducible Factor-dependent Gene, Cooperates with Macrophage Migration Inhibitory Factor in Renal Tumorigenesis
    Vinay Pasupuleti, Weinan Du, Yashi Gupta, I‐Ju Yeh, Monica M. Montano, Cristina Magi-Galuzzi, Scott M. Welford · 2013 · Journal of Biological Chemistry
  48. Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan
    Yongzhen Hu, Keita Kirito, Kozue Yoshida, Toru Mitsumori, Kei Nakajima, Yumi Nozaki, Satoshi Hamanaka, Takahiro Nagashima, Masae Kunitama, Kumi Sakoe et al. · 2009 · Molecular Cancer Therapeutics
  49. Hypoxia-Mediated Induction of the Polyamine System Provides Opportunities for Tumor Growth Inhibition by Combined Targeting of Vascular Endothelial Growth Factor and Ornithine Decarboxylase
    Katrin J. Svensson, Johanna E. Welch, Paulina Kucharzewska, Per Bengtson, Maria Bjurberg, Sven Påhlman, Gerdy B. ten Dam, Lo Persson, Mattias Belting · 2008 · Cancer Research
  50. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling
    Taeryool Koo, Bong Jun Cho, Dan Hyo Kim, Ji Min Park, Eun Jung Choi, Hans H. Kim, David J. Lee, In Ah Kim · 2017 · Oncotarget
  51. An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia
    Kerri‐Ann Norton, Travis Wallace, Niranjan B. Pandey, Aleksander S. Popel · 2017 · BMC Systems Biology
  52. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
    Andrea L. Casillas, Rachel K. Toth, Alva G. Sainz, Neha Singh, Ankit A. Desai, Andrew S. Kraft, Noel A. Warfel · 2017 · Clinical Cancer Research
  53. The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor–1α in macrophages via sphingosine-1-phosphate and transforming growth factor-β
    Barbara Herr, Jie Zhou, Christian Werno, Heidi Menrad, Dmitry Namgaladze, Andreas Weigert, Nathalie Dehne, Bernhard Brüne · 2009 · Blood
  54. Why are epididymal tumours so rare?
    Ching‐Hei Yeung, Kai Wang, Trevor G. Cooper · 2012 · Asian Journal of Andrology
  55. Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1
    Luke Harrison, Dimitra Micha, Martin Brandenburg, Kathryn Simpson, Christopher J. Morrow, O. Denneny, Cassandra L. Hodgkinson, Zaira Yunus, Clare E. Dempsey, Darren L. Roberts et al. · 2011 · Journal of Clinical Investigation
  56. Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis
    Ming-xiao Zhang, Lizhen Zhang, Liangmin Fu, Haohua Yao, Lei Tan, Zihao Feng, Jiaying Li, Jun Kun Lu, Yihui Pan, Guannan Shu et al. · 2021 · Oncogene
  57. HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells
    Lihua Wu, Haiyang Yu, Yuhan Zhao, Cen Zhang, Jiabei Wang, Xuetian Yue, Qifeng Yang, Wenwei Hu · 2015 · Oncotarget
  58. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α
    Qilin Ao, Wenjing Su, Shuang Guo, Lei Cai, Lei Huang · 2015 · Scientific Reports
  59. MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma
    Alessia Lo Dico, Viviana Costa, Cristina Martelli, Cecilia Diceglie, Francesca Raiata, Aroldo Gabriele Rizzo, Carmine Mancone, Marco Tripodi, Luisa Ottobrini, Riccardo Alessandro et al. · 2016 · Theranostics
  60. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway
    Xinlu Liu, Xiaodong Tan, Peng Liu, Yunhao Wu, Songying Qian, Xiaobo Zhang · 2018 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  61. Redox Control of Protein–DNA Interactions: From Molecular Mechanisms to Significance in Signal Transduction, Gene Expression, and DNA Replication
    Joseph Shlomai · 2010 · Antioxidants and Redox Signaling
  62. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer
    Veronique M. Neumeister, Catherine A.W. Sullivan, Robert M. Lindner, Kimberly Lezon-Geyda, Jia Li, J Závada, Maritza Martel, Peter M. Glazer, David P. Tuck, David L. Rimm et al. · 2012 · Breast Cancer Research and Treatment
  63. Vasculogenic Mimicry of HT1080 Tumour Cells In Vivo: Critical Role of HIF-1α-Neuropilin-1 Axis
    Roli M. Misra, Manmohan S. Bajaj, Vaijayanti Prakash Kale · 2012 · PLoS ONE
  64. c-Jun Protects Hypoxia-Inducible Factor-1α from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner
    Bing Yu, Ze‐Hong Miao, Yi Jiang, Mei-Hong Li, Na Young Yang, Ting Li, Jian Ding · 2009 · Cancer Research
  65. Angiogenic signaling aberrantly induced by tumor hypoxia
    Keizo Takenaga · 2010 · Frontiers in bioscience
  66. Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets
    Vincenza Barresi, Camillo Musmeci, Alessandro Rinaldi, D. F. Condorelli · 2022 · International Journal of Molecular Sciences
  67. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma
    Theresa Geis, Claudia Döring, Rüdiger Popp, Nina Grossmann, Ingrid Fleming, Martin‐Leo Hansmann, Nathalie Dehne, Bernhard Brüne · 2014 · Experimental Cell Research
  68. Downregulation of PHLPP Expression Contributes to Hypoxia-Induced Resistance to Chemotherapy in Colon Cancer Cells
    Yang‐An Wen, Payton D. Stevens, Michael L. Gasser, Romina Andrei, Tianyan Gao · 2013 · Molecular and Cellular Biology
  69. Endothelial-Specific Deficiency of ATG5 (Autophagy Protein 5) Attenuates Ischemia-Related Angiogenesis
    David Sprott, David M. Poitz, Irina Korovina, Athanasios Ziogas, Julia Phieler, Antonios Chatzigeorgiou, Ioannis Mitroulis, Andreas Deußen, Triantafyllos Chavakis, Anne Klotzsche–von Ameln · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
  70. Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
    Shinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kentaro Igarashi, Hiroyuki Tsuchiya · 2022 · International Journal of Molecular Sciences
  71. Regulation of tumor angiogenesis by the local environment.
    Kelly L. Hall, S. Ran · 2010 · Frontiers in Bioscience
  72. Partial Bladder Outlet Obstruction in Mice May Cause E-Cadherin Repression through Hypoxia Induced Pathway
    Naoko Iguchi, Amy H. Hou, Hari K. Koul, Duncan T. Wilcox · 2014 · The Journal of Urology
  73. Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in vivo bioluminescence imaging study
    Qing Zeng, Zhong Hui Yang, Yong‐Jing Gao, Huaiping Yuan, Kemi Cui, Ying Shi, Hongyun Wang, Xudong Huang, Stephen T. C. Wong, Yaming Wang et al. · 2010 · European Journal of Cancer
  74. Peroxisome Proliferator Activated Receptor-α/Hypoxia Inducible Factor-1α Interplay Sustains Carbonic Anhydrase IX and Apoliprotein E Expression in Breast Cancer Stem Cells
    Alessio Papi, Gianluca Storci, Tiziana Guarnieri, Sabrina De Carolis, Sara Bertoni, Nicola Avenia, Alessandro Sanguinetti, Angelo Sidoni, Donatella Santini, Claudio Ceccarelli et al. · 2013 · PLoS ONE
  75. The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer
    Andika Chandra Putra, Hidetaka Eguchi, Kian Leong Lee, Yuko Yamane, Ewita Gustine, Takeshi Isobe, Masahiko Nishiyama, Keiko Hiyama, Lorenz Poellinger, Keiji Tanimoto · 2015 · PLoS ONE
  76. Novel hypoxia-targeting Pt( iv ) prodrugs
    Zichen Xu, Jian Zhao, Shao-Hua Gou, Gang Xu · 2017 · Chemical Communications
  77. Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation
    Ola H. Rizk, Mohamed Teleb, Marwa Muhammad Abu-Serie, Omaima G. Shaaban · 2019 · Bioorganic Chemistry
  78. The Alternative Medicine Pawpaw and Its Acetogenin Constituents Suppress Tumor Angiogenesis via the HIF-1/VEGF Pathway
    Veena Coothankandaswamy, Yang Liu, Shui‐Chun Mao, J. Brian Morgan, Fakhri Mahdi, Mika B. Jekabsons, Dale G. Nagle, Yudong Zhou · 2010 · Journal of Natural Products
  79. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
    Fu Ou‐Yang, Ming‐Feng Hou, Sheau‐Fang Yang, Soon-Cen Huang, Wen‐Ying Lee · 2009 · PubMed
  80. The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment
    Yijie Wang, Xiong Liu, Weixiao Huang, Junjie Liang, Yan Chen · 2022 · Pharmacology & Therapeutics
  81. In Vivo Topoisomerase I Inhibition Attenuates the Expression of Hypoxia-Inducible Factor 1α Target Genes and Decreases Tumor Angiogenesis
    Guérin, Eric, Raffelsberger, Wolfgang, Pencreach, Erwan, Maier, Armin, Neuville, Agnès, Schneider, Anne, Bachellier, Philippe, Rohr, Serge, Petitprez, Amélie, Poch, Olivier et al. · 2012 · Molecular Medicine
  82. Increased HIF-1α Expression Correlates With Cell Proliferation and Vascular Markers CD31 and VEGF-A in Uveal Melanoma
    F. Mouriaux, François Sanschagrin, Caroline Diorio, Solange Landreville, François Comoz, Edwige Petit, Myriam Bernaudin, Alain P. Rousseau, Dan Bergeron, Mohib Morcos · 2014 · Investigative Ophthalmology & Visual Science
  83. Triptolide, a Chinese Herbal Extract, Enhances Drug Sensitivity of Resistant Myeloid Leukemia Cell Lines Through Downregulation of HIF-1α and Nrf2
    Feili Chen, Yuejian Liu, Shiyun Wang, Xutao Guo, Pengcheng Shi, Weiguang Wang, Bing Xu · 2013 · Pharmacogenomics
  84. Fine Tuning of the UPR by the Ubiquitin Ligases Siah1/2
    Marzia Scortegagna, Hyungsoo Kim, Jian‐Liang Li, Hang Yao, Laurence M. Brill, Jaeseok Han, Eric K. Lau, David D.L. Bowtell, Gabriel Haddad, Randal J. Kaufman et al. · 2014 · PLoS Genetics
  85. Gambogic acid inhibits angiogenesis through inhibiting PHD2–VHL–HIF-1α pathway
    Na Lu, Hui Hui, Hao Yang, Kai Zhao, Yan Chen, Qidong You, Qinglong Guo · 2013 · European Journal of Pharmaceutical Sciences
  86. Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro
    Ramya Krishna Vadlapatla, Aswani Dutt Vadlapudi, Dhananjay Pal, Mridul Mukherji, A K Mitra · 2013 · Eye
  87. Glioblastoma niches: from the concept to the phenotypical reality
    Davide Schiffer, Marta Mellai, Enrica Bovio, Ilaria Bisogno, Cristina Casalone, Laura Annovazzi · 2018 · Neurological Sciences
  88. Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer
    Davide Povero, Scott M. Johnson, Jun Liu · 2020 · Cancer Letters
  89. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery
    Meghna Talekar, Srinivas Reddy Boreddy, Amit Singh, Mansoor M. Amiji · 2014 · Expert Opinion on Biological Therapy
  90. HIF-1α is a Prognostic Marker in Oral Squamous Cell Carcinomas
    Alexander W. Eckert, Andreas Schütze, M.H.W. Lautner, Helge W. Taubert, Johannes Schubert, Udo Bilkenroth · 2010 · The International Journal of Biological Markers
  91. Epigenetic dynamics in cancer stem cell dormancy
    Alejandra I. Ferrer, Jonathan R. Trinidad, Oleta A. Sandiford, Jean‐Pierre Etchegaray, Pranela Rameshwar · 2020 · Cancer and Metastasis Reviews
  92. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomas
    Xiaoxiang Li, Zhenwei Ji, Yunlei Ma, Xiuchun Qiu, Qingyu Fan, Baoan Ma · 2012 · Oncology Letters
  93. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study
    Zhen Wang, Qin Shi, Zemin Wang, Yongping Gu, Yueping Shen, Mao-ming Sun, Min Deng, Hua Zhang, Fang Junchu, Shuying Zhang et al. · 2011 · Pathology - Research and Practice
  94. Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines
    Siddarth Chandrasekaran, Yue Geng, Lisa A. DeLouise, Michael R. King · 2012 · Biomaterials
  95. Tax contributes apoptosis resistance to HTLV-1-infected T cells via suppression of Bid and Bim expression
    Annette Mühleisen, Marco Giaisi, Rebecca Köhler, Peter H. Krammer, M Li-Weber · 2014 · Cell Death and Disease
  96. Reactive oxygen species and synthetic antioxidants as angiogenesis modulators: Clinical implications
    Dorota Magdalena Radomska-Leśniewska, Agata Hevelke, Piotr Skopiński, Barbara Joanna Bałan, Jarosław Jóźwiak, Dariusz Rokicki, Ewa Skopińska-Różewska, Agata Białoszewska · 2015 · Pharmacological Reports
  97. Artificial neural network classifier predicts neuroblastoma patients’ outcome
    Davide Cangelosi, Simone Pelassa, Martina Morini, Massimo Conte, Maria Carla Bosco, Alessandra Eva, Angela Rita Sementa, Luigi Varesio · 2016 · BMC Bioinformatics
  98. PTBP3 promotes malignancy and hypoxia‐induced chemoresistance in pancreatic cancer cells by ATG12 up‐regulation
    Jun Ma, Li Weng, Yiping Jia, Bingyan Liu, Shaoqiu Wu, Lei Xue, Xiang Yin, Aiwu Mao, Zhongmin Wang, Mingyi Shang · 2020 · Journal of Cellular and Molecular Medicine
  99. Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α
    Ji Cao, Lingjuan He, Guanyu Lin, Chunqi Hu, Rong Dong, Jun Zhang, Hong Zhu, Yongzhou Hu, Carston R. Wagner, Qiaojun He et al. · 2013 · Biochemical Pharmacology
  100. Role of Carcinoma-Associated Fibroblasts and Hypoxia in Tumor Progression
    Amato J. Giaccia, Ernestina Schipani · 2010 · Current topics in microbiology and immunology